A0833750
HU-308 , ≥98% , 256934-39-1
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB559.20 | In Stock |
|
| 5mg | RMB2399.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 508.7±50.0 °C(Predicted) |
| Density | 0.999 |
| storage temp. | Store at -20°C |
| solubility | Soluble in DMSO |
| pka | 14.77±0.10(Predicted) |
| form | solution in methyl acetate |
| color | white to dark beige |
| optical activity | [α]/D 180.0 to 130.0°, c =0.5 in chloroform-d |
| InChI | 1S/C27H42O3/c1-8-9-10-11-12-26(2,3)19-14-23(29-6)25(24(15-19)30-7)20-13-18(17-28)21-16-22(20)27(21,4)5/h13-15,20-22,28H,8-12,16-17H2,1-7H3/t20-,21+,22-/m0/s1 |
| InChIKey | CFMRIVODIXTERW-BDTNDASRSA-N |
| SMILES | [C@]12([H])C[C@]([H])(C1(C)C)[C@@H](C1=C(OC)C=C(C(C)(C)CCCCCC)C=C1OC)C=C2CO |
Description and Uses
A specific CB2-specific agonist that inhibits forskolin-stimulated cAMP production in CB2-transfected cells. It reduces blood pressure, blocks defecation, and elicits anti-inflammatory and peripheral analgesic activity and thus may lead to new therapies for hypertension, inflammation, and pain. Controlled Substance.
Safety
| Symbol(GHS) |   GHS02,GHS07 |
| Signal word | Danger |
| Hazard statements | H225-H319-H336 |
| Precautionary statements | P210-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P337+P313-P370+P378-P403+P233-P403+P235-P405-P501 |
| WGK Germany | WGK 3 |
| Storage Class | 11 - Combustible Solids |
